Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-15

Clinical Trial Update: PriMatrix for the Management of Diabetic Foot Ulcers [NA]

View source ↗

Summary

Completed clinical trial update for PriMatrix in the management of diabetic foot ulcers; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PriMatrix (acellular dermal matrix)

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Diabetic Foot Ulcer | NA | Status: COMPLETED | Results posted: 2022-03-15